Kit for detecting residual DNA content and fragment size distribution of E.coli cells and application of kit
By using specific primers and probe combinations in the qPCR amplification system, the problem of residual DNA detection in E.coli host cells was solved, and the rapid and sensitive DNA fragment size distribution analysis was achieved, which improved the safety in biological product production Monitoring efficiency.
Patent Information
- Application Number
- CN202411260339.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-10
- Publication Date
- 2024-12-06
AI Technical Summary
The prior art is difficult to effectively detect and analyze the content and fragment size distribution of residual DNA in E.coli host cells, resulting in difficulty in monitoring the safety of biological products, and the detection time is long and unstable, which cannot meet the increasingly stringent detection needs.
A kit for detecting residual DNA content and fragment size distribution of E.coli cells is provided. It uses a Taq enzyme with low E.coli host residual DNA configuration qPCR amplification system, and uses specific combinations of primers and probes to enable quantitative detection at the same time. Different fragment sizes of E.coli cell DNA include sequences below 100 bp, 100-199 bp, 200-499 bp and 500-600 bp.
It realizes fast and highly sensitive detection, can complete product testing within 4 hours, and the quantitative limit is up to 10fg/μL. It can accurately distinguish interfering DNA from different cell types and improves the quality control efficiency in biological products production.
Smart Images

Figure CN119082326A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of molecular biology and relates to the detection of residual DNA of host cells in biological products, and specifically to a kit for detecting the residual DNA content and fragment size distribution of E. coli cells and its application. Background Art
[0002] The raw materials used in the research and production of biological products are mostly microorganisms such as bacteria and viruses, as well as tissues, cells, body fluids, etc. The inherent characteristics of raw materials can cause potential dangers. Therefore, the biosafety issues in the research and development and production of biological products have attracted widespread attention and great attention from countries around the world. In addition, if biological products carry exogenous contaminants, especially infectious pathogenic microorganisms, biological products may become a medium for spreading epidemics, which will seriously threaten human health. Therefore, all countries attach great importance to the safety of biological products.
[0003] Recombinant biological products are mostly produced by genetically modified host cells. Their products also contain a large number of non-target products. These products come from host cells and have a direct impact on the safety of biological products. In particular, residual DNA in host cells is a common contaminant and an important part of biological product quality control.
[0004] In production, host cell residual DNA (HCD) is a process-related impurity that may exist in the final product. The content and distribution of HCD may cause tumorigenicity and infectivity, and has attracted the attention of the industry and regulatory agencies. Existing studies have shown that the functional gene for HCD pathogenicity must be at least 200bp, so the larger the residual DNA fragment, the higher the risk level. At present, for many biological products based on host cell culture, it is necessary to monitor the fragment distribution and content of HCD. For example, the U.S. Food and Drug Administration (FDA) and the China National Medical Products Administration (NMPA) have clearly stated in the production guidance type documents for new gene therapy products that the HCD fragment must be less than 200bp. There is also the possibility of HCD residues in recombinant biological products, so it is necessary to evaluate the size distribution of HCD fragments in the final product.
[0005] E. coli is a common host bacteria for genetic engineering and is widely used in the production of biological products. It has obvious economic advantages because it has been thoroughly studied, the conditions required for the cultivation of E. coli are mild, the threshold is low, and the metabolism is rapid. The third volume of the 2020 edition of the Chinese Pharmacopoeia stipulates that the residual DNA content of biological preparations produced in cell matrices cannot exceed 100pg / dose, and the residual DNA content of vaccines produced in bacterial or fungal matrices cannot exceed 10ng / dose.
[0006] For the quantitative detection of residual host cell DNA in biological products, conventional methods in the existing technology include: DNA probe hybridization method, fluorescent dye method, threshold method, etc. However, due to the long detection time and lack of stability, they can no longer meet the increasingly stringent detection needs and have been gradually eliminated in some countries.
[0007] qPCR technology is currently widely used in the field of biological product testing. A specific fluorescent probe is added during the amplification process, and the increase of the product is reflected by the change in the fluorescent signal, so that the initial residual template amount in the sample can be quantitatively analyzed. Due to the advantages of TaqMan probe technology in accuracy, sensitivity, specificity, etc., it is widely used in the fields of gene quantification and gene mutation detection.
[0008] In the process of detecting residual host cell DNA, in order to improve the sensitivity of detection, multi-copy sequences are generally selected as the target of detection. Compared with animal cells, the genome size of Escherichia coli E.coli is only one thousandth of the former, so the requirement for the copy number can be appropriately reduced. In the prior art, scholars at home and abroad generally use 16S rDNA and 23SrDNA of bacteria as ideal targets for bacterial classification and detection. In addition, the DNA polymerases used in large quantities in qPCR amplification are generally E.coli recombinases, and it is inevitable that there are trace amounts of E.coli genomic DNA, including E.coli ribosomal DNA, which leads to negative well jumps during qPCR. In order to solve this problem, the present invention uses Taq enzymes with low E.coli host residual DNA to configure the qPCR amplification system, which not only ensures the high sensitivity of the system, but also reduces the interference of E.coli host residual DNA in the raw materials with the detection process. Summary of the invention
[0009] Technical problem to be solved: In order to overcome the shortcomings of the prior art, the residual DNA content and fragment size distribution of E. coli host bacteria can be accurately quantified and analyzed; in view of this, the present invention provides a kit for detecting the residual DNA content and fragment size distribution of E. coli cells and its application.
[0010] Technical solution: A kit for detecting the residual DNA content and fragment size distribution of E. coli cells, wherein the kit uses E. coli cell genomic DNA as the detection target, and the target sequence is SEQ ID NO.1; and comprises at least 4 sets of primers and probe combinations for amplifying the SEQ ID NO.1 sequence.
[0011] Preferably, the lengths of the amplification products of the four sets of primer and probe combinations are: less than 100 bp, 100-199 bp, 200-499 bp, and 500-600 bp, respectively.
[0012] Furthermore, the 5' end of the probe is labeled with a fluorescent reporter group, which is preferably FAM, or other groups with similar functions, and the 3' end is labeled with a quencher group, which is preferably BHQ1, or other groups with similar functions.
[0013] Preferably, the four sets of primer and probe combinations share the same forward primer, whose sequence is SEQ ID NO.2; the reverse primer sequences are SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6 respectively; the four sets of primer and probe combinations share the same probe, whose sequence is SEQ ID NO.7.
[0014] Further, in the first set of primers, the forward primer binds to positions 884-904 of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells; the reverse primer binds to positions 956-975 of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells, and the length of the amplified product obtained by amplification by the primer pair is 93 bp. In the second set of primers, the forward primer binds to positions 884-904 of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells; the reverse primer binds to positions 1057-1077 of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells, and the length of the amplified product obtained by amplification by the primer pair is 195
[0015] bp. The third set of primers, the forward primer binds to the 884-904th position of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells; the reverse primer binds to the 1088-1111th position of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells, and the length of the amplification product obtained by amplification by the primer pair is 228bp. The fourth set of primers, the forward primer binds to the 884-904th position of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells; the reverse primer binds to the 1371-1392th position of the SEQ ID NO.1 sequence on the genomic DNA of E. coli cells, and the length of the amplification product obtained by amplification by the primer pair is 510bp. The probe sequence SEQ ID NO.7 binds to the 905-936th position of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0016] Among them, the Tm value of the first set of primers, the forward primer and the reverse primer are 60.41-60.68°C, and the absolute value of the difference in Tm is ≤1°C. The Tm value of the second set of primers, the forward primer and the reverse primer are 59.3-60.41°C, and the absolute value of the difference in Tm is ≤1°C. The Tm value of the third set of primers, the forward primer and the reverse primer are 60.41-60.68°C, and the absolute value of the difference in Tm is ≤1°C. The Tm value of the fourth set of primers, the forward primer and the reverse primer are 60.41-59.3°C, and the absolute value of the difference in Tm is ≤1°C.
[0017] Preferably, the final concentrations of the four sets of primers and probes used in the amplification system are:
[0018] For the first set of primers and probes, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 3 were 0.24 μM, and the final concentration of SEQ ID NO. 7 was 0.12 μM;
[0019] For the second set of primers and probes, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 4 were 0.267 μM, and the final concentration of SEQ ID NO. 7 was 0.133 μM;
[0020] For the third set of primers and probes, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 5 were 0.267 μM, and the final concentration of SEQ ID NO. 7 was 0.133 μM;
[0021] For the fourth set of primers and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 6 were 0.293 μM, and the final concentration of SEQ ID NO. 7 was 0.147 μM.
[0022] Preferably, the kit includes IPC Mix, which is added to each set of primer and probe combinations respectively; the IPCMix includes an IPC template plasmid and an IPC primer probe combination, wherein the IPC template plasmid is an artificially modified cloning plasmid with a sequence of SEQ ID NO.8, the IPC forward primer sequence is SEQ ID NO.9, the IPC reverse primer sequence is SEQ ID NO.10, and the IPC probe sequence is SEQ ID NO.11.
[0023] Preferably, the final concentrations of the IPC template plasmid and the IPC primer probe combination in the amplification system are:
[0024] The final concentration of SEQ ID NO.8 was 2.48×10 5copies / mL; the final concentration of SEQ ID NO.9 and SEQ ID NO.10 was 0.3 μM; the final concentration of SEQ ID NO.11 was 0.106 μM.
[0025] Preferably, the kit comprises 2×qPCR Mix, E. coli quantitative standard and DNA diluent; wherein the 2×qPCR Mix comprises 40mM Tris-HCl pH 7.8, 0.1U / μL Taq enzyme, 0.6mM dNTPs, 100nM ROX reference dye, 8mM Mg 2+ , 20% glycerol. The E. coli quantitative standard is E. coli cell genomic DNA, with a concentration of 30ng / μL. The DNA diluent includes Tween-20 at a concentration of 0.1-0.2%, Tris-HCl at a concentration of 5.0-10.0mM, EDTA at a concentration of 0.05-0.1mM, and NaOH solution is used to adjust the pH to 6.0-8.5.
[0026] The use of any of the above-mentioned kits in the quantitative detection of E. coli cell DNA content and fragment size distribution in intermediates, semi-finished products and finished products of biological products.
[0027] Preferably, the biological products are produced using an E. coli cell expression system, including antibody drugs, vaccines and recombinant proteins.
[0028] Preferably, the kit can accurately distinguish E. coli cell DNA fragments in biological products with a size of less than 100 bp, 100-199 bp, 200-499 bp, and 500-600 bp, and the quantitative limit of each detection system is 10 fg / μL.
[0029] Beneficial effects: (1) The kit of the present invention has established a qPCR detection method that can simultaneously and quantitatively detect the E. coli host bacteria and the size distribution of each fragment through screening and analysis of the detection target, primer probe design and detection system optimization, which provides convenience for biological product manufacturers and improves product quality control efficiency; (2) The application of the kit can control the product detection time within 4 hours, with high sensitivity and a quantitative limit of 10fg / μL, and strong specificity; (3) The kit can distinguish interfering DNA from CHO cells, Vero cells, HEK293 cells, Pichia pastoris cells, etc. BRIEF DESCRIPTION OF THE DRAWINGS
[0030] Figure 1 This is the amplification curve when the length of the amplified fragment of the kit of the present invention is 93 bp;
[0031] Figure 2This is a linear relationship diagram when the length of the amplified fragment of the kit of the present invention is 93 bp;
[0032] Figure 3 is the amplification curve when the length of the amplified fragment of the kit of the present invention is 195 bp;
[0033] Figure 4 This is a linear relationship diagram when the length of the amplified fragment of the kit of the present invention is 195 bp;
[0034] Figure 5 This is an amplification curve diagram when the length of the amplified fragment of the kit of the present invention is 228 bp;
[0035] Figure 6 This is a linear relationship diagram when the length of the amplified fragment of the kit of the present invention is 228 bp;
[0036] Figure 7 This is an amplification curve diagram when the length of the amplified fragment of the kit of the present invention is 510 bp;
[0037] Figure 8 This is a linear relationship diagram when the length of the amplified fragment of the kit of the present invention is 510 bp;
[0038] Fig. 9 It is an amplification curve of the quantitative limit test when the length of the amplified fragment of the kit of the present invention is 93 bp;
[0039] Fig.10 is an amplification curve of the quantitative limit test when the length of the amplified fragment of the kit of the present invention is 195 bp;
[0040] Fig.11 It is an amplification curve of the quantitative limit test when the length of the amplified fragment of the kit of the present invention is 228 bp;
[0041] Fig.12 It is an amplification curve of the quantitative limit test when the length of the amplified fragment of the kit of the present invention is 510 bp. DETAILED DESCRIPTION
[0042] The following examples further illustrate the content of the present invention, but should not be construed as limiting the present invention. Without departing from the spirit and essence of the present invention, modifications and substitutions made to the method, steps or conditions of the present invention all belong to the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art.
[0043] Example 1
[0044] 1. Primer pairs of the present invention
[0045]
[0046] The sequence shown in SEQ ID NO.2 is specifically: GACTTACCAACCCGATGCAAAC, which binds to positions 884-904 of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0047] The sequence shown in SEQ ID NO.3 is specifically: TGTTTCCCTCTTCACGACGG, which binds to positions 956-975 of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0048] The sequence shown in SEQ ID NO.4 is specifically: GCTGCTTCTAAGCCAACATCC, which binds to positions 1057-1077 of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0049] The sequence shown in SEQ ID NO.5 is specifically: ACCAGTGAGCTATTACGCTTTCTT, which binds to positions 1088-1111 of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0050] The sequence shown in SEQ ID NO.6 is specifically: AACCTGTTTCCCATCGACTACG, which binds to positions 1371-1392 of the sequence shown in SEQ ID NO.1 on the genomic DNA of E. coli cells.
[0051] In this embodiment, the primer pair is selected from the following primer pairs:
[0052] The first pair of primers: the forward primer is shown in SEQ ID NO.2, and the reverse primer is shown in SEQ ID NO.3;
[0053] The second pair of primers: the forward primer is shown in SEQ ID NO.2, and the reverse primer is shown in SEQ ID NO.4;
[0054] The third pair of primers: the forward primer is shown in SEQ ID NO.2, and the reverse primer is shown in SEQ ID NO.5;
[0055] The fourth pair of primers: the forward primer is shown as SEQ ID NO.2, and the reverse primer is shown as SEQ ID NO.6.
[0056] 2. Probes of the present invention
[0057] In a specific embodiment, the probe of the present invention is as shown in SEQ ID NO. 7. The sequence shown in SEQ ID NO. 7 is specifically: FAM-CGATGCAAACTGCGAATACCGGAGAATGTTAT-BHQ1, which binds to the 905-936th position of the sequence shown in SEQ ID NO. 1 on the genomic DNA of E. coli cells.
[0058] 3. Detection reagents of the present invention
[0059] The present invention also provides a detection reagent for quantitatively detecting residual DNA in E. coli cells, wherein the detection reagent comprises the primer pair and probe of the present invention and other components required for PCR reaction, such as 2×qPCRMix, E. coli DNA quantitative standard and DNA diluent.
[0060] The first pair of primers and probe combination: the forward primer is shown in SEQ ID NO.2; the reverse primer is shown in SEQ ID NO.3, and the probe is shown in SEQ ID NO.7. The length of the amplified product obtained by the detection reagent is 93 bp.
[0061] The second pair of primers and probe combination: the forward primer is shown in SEQ ID NO.2; the reverse primer is shown in SEQ ID NO.4, and the probe is shown in SEQ ID NO.7. The length of the amplified product obtained by the detection reagent is 195 bp.
[0062] The third pair of primers and probe combination: the forward primer is shown as SEQ ID NO.2; the reverse primer is shown as SEQ ID NO.5, and the probe is shown as SEQ ID NO.7. The length of the amplified product obtained by amplifying the detection reagent is 228 bp.
[0063] The fourth pair of primers and probe combination: the forward primer is shown as SEQ ID NO.2; the reverse primer is shown as SEQ ID NO.6, and the probe is shown as SEQ ID NO.7. The length of the amplified product obtained by the detection reagent is 510 bp.
[0064] IV. Materials, instruments and methods used in the present invention
[0065] 1. Materials
[0066] Unless otherwise specified, the materials and reagents used in the present invention can be obtained from commercial sources. Among them, 2×qPCRMix, DNA diluent, E. coli DNA quantitative standard, Vero DNA quantitative standard, Human DNA quantitative standard, CHODNA quantitative standard, Pichia pastoris DNA quantitative standard and magnetic bead method trace residual nucleic acid extraction kit are all from Jiangsu Anke Huajie Biotechnology Co., Ltd.;
[0067] The primer pairs and probes are combined to obtain several different systems as shown in Table 1 below.
[0068] Table 1. Combinations of primers and probes in four detection systems
[0069] Combination Product size System 1 SEQ ID NO.2, SEQ ID NO.7, SEQ ID NO.3 93bp System 2 SEQ ID NO.2, SEQ ID NO.7, SEQ ID NO.4 195bp System 3 SEQ ID NO.2, SEQ ID NO.7, SEQ ID NO.5 228bp System 4 SEQ ID NO.2, SEQ ID NO.7, SEQ ID NO.6 510bp
[0070] In order to monitor the qPCR reaction process, IPC Mix was added to the four detection systems, where the IPC template plasmid was the artificially modified clone plasmid SEQ ID NO.8, and the specific sequence is as follows:
[0071] CGCCACGGTCACGGAGCACGAGAAATTCCACTTTACCCACCGTGAACGCCGTAAT CATTGGATCTACTTTCCTTCTACGCCAAGTAAATCAATTGTTTGCTTCAACCATCATTTCGGCTTTGAACGTGCCGCTTGATACTGACA.
[0072] The forward primer sequence is SEQ ID NO.9; the reverse primer sequence is SEQ ID NO.10; the probe sequence is SEQ ID NO.11. The specific primer and probe sequences are shown in Table 2 below:
[0073] Table 2. IPC primer probe sequences
[0074] Sequence number Sequence (5'→3') Forward primer SEQ ID NO.9 CGCCACGGTCACGGAGCAC Reverse primer SEQ ID NO.10 TCAGTATCAAGCGGCACGTT Probe sequence SEQ ID NO.11 VIC-GTGAACGCCGTAATCATTGGATCTA-BHQ1
[0075] 2. Instruments
[0076] The fluorescent quantitative PCR instruments used in the present invention are mainly ABI 7500, ABI QuantStudio Dx and ABI QuantStudio 5 from the United States.
[0077] 3. Methods
[0078] 3.1 Preparation of standard curve samples
[0079] The E. coli DNA quantitative standard was diluted 10-fold with DNA diluent to prepare standard solutions of 300 pg / μL, 30 pg / μL, 3 pg / μL, 0.3 pg / μL, 0.03 pg / μL, and 0.003 pg / μL.
[0080] 3.2qPCR reaction system
[0081] Determine the reagents and amounts required for the reaction, premix 2×qPCR Mix with primer probes to make qPCR reaction solution, and aliquot. Detection system 30μL: 20μL qPCR reaction solution + 10μL template.
[0082] 3.3qPCR detection
[0083] The reaction program was set on the fluorescence quantitative PCR instrument: pre-denaturation at 95°C for 2 min; 95°C for 5 s, 60°C for 30 s, 72°C for 30 s (reading fluorescence), 38 cycles; reaction volume was 30 μL.
[0084] 3.4 Data Analysis
[0085] After amplification, set the threshold line and read the amplification efficiency, slope, and R 2 and the test values of each sample.
[0086] 3.5 Result determination
[0087] Correlation coefficient R of the standard curve equation 2 Should be greater than 0.99, with a slope between -3.58 and -3.1 (i.e., amplification efficiency between 90.0 and 110.0%)
[0088] The Ct values of negative control, no template control (NTC) and interfering DNA were greater than the quantification limit Ct value.
[0089] 3.6 Calculation of fragment size distribution
[0090] Taking the detection value of the sample to be tested of the 93 bp fragment as 100%, the percentages of the sample to be tested of the 195 bp fragment, the 228 bp fragment, and the 510 bp fragment were calculated.
[0091] V. Test Results
[0092] 1. Linear range
[0093] Amplify the standard curves of four different fragment detection systems and calculate the standard curve correlation coefficient (R 2 ) and amplification efficiency (En). The results showed that the linear range of the established four different fragment detection systems was 300pg / μL~30fg / μL, and the calibration curve R 2≥0.990, En is 90.0~110.0%, NTC Ct value is ≥34.00, IPC Ct value is ≤32.00.
[0094] The amplification curves and linear relationship diagrams of the standard curves of system 1-system 4 are as follows: Figure 1-8 As shown, Table 3 is a table of linear range detection results of four different fragment detection systems.
[0095] Table 3. Linear range test results of four different fragment detection systems
[0096]
[0097] 2. Exclusivity
[0098] The interference of genomic DNA of four cells or bacteria, CHO, HEK293, Vero and Pichia, which are commonly used in the production of engineered cell genomes, on the detection system of different fragments of E. coli was evaluated. The results showed that the concentration of the four selected interfering genomic DNAs was 3pg / μL, the detection Ct value was ≥35.00, and the Ct value of the interference group was ≥Ct(NTC) or the detection value of the interference group was <0.003pg / μL, indicating that they had no interference with the four detection systems established by the present invention, and the system showed strong specificity. Table 4 is a table of specificity test results of four different fragment detection systems.
[0099] Table 4 Specificity test results
[0100]
[0101] 3. Limit of Quantitation
[0102] The standard curves of four different fragment detection systems (300pg / μL to 10fg / μL) were amplified, and the detection Ct values of each group at a template amount of 10fg / μL (10 replicate wells) were measured at the same time. The detection Ct values were substituted into the standard curve to calculate the detection concentration of each well, and the coefficient of variation (CV) and deviation of the detection concentration of 10 replicate wells were calculated. The results showed that the CV and deviation of the 10fg / μL detection concentration of each system were ≤20.0%, and the quantitative limit was 10fg / μL. The amplification curves of the quantitative limit test were as follows: Figure 9-12 The quantitative limit detection results are shown in Table 5.
[0103] Table 5. Quantitation limit detection results
[0104]
Claims
1. A kit for detecting the residual DNA content and fragment size distribution of E. coli cells, characterized in that: The kit uses E. coli cell genomic DNA as the detection target, and the target sequence is SEQ ID NO.1; It includes at least 4 sets of primers and probe combinations for amplifying the sequence of SEQ ID NO.
1.
2. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 1, characterized in that: The lengths of the amplified products of the four sets of primers and probe combinations are respectively: less than 100 bp, 100-199 bp, 200-499 bp, and 500-600 bp.
3. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 1, characterized in that: The four sets of primer and probe combinations share the same forward primer, whose sequence is SEQ ID NO.2; the reverse primer sequences are SEQ ID NO.3, SEQ ID NO.4, SEQ ID NO.5 and SEQ ID NO.6 respectively; the four sets of primer and probe combinations share the same probe, whose sequence is SEQ ID NO.
7.
4. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 1, characterized in that: The final concentrations of the four sets of primers and probes used in the amplification system are: For the first set of primer and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 3 were 0.24 μM, and the final concentration of SEQ ID NO. 7 was 0.12 μM; For the second set of primers and probes, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 4 were 0.267 μM, and the final concentration of SEQ ID NO. 7 was 0.133 μM; For the third set of primers and probes, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 5 were 0.267 μM, and the final concentration of SEQ ID NO. 7 was 0.133 μM; For the fourth set of primers and probe combinations, the final concentrations of SEQ ID NO. 2 and SEQ ID NO. 6 were 0.293 μM, and the final concentration of SEQ ID NO. 7 was 0.147 μM.
5. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 1, characterized in that: The kit includes IPC Mix, which is added to each set of primer and probe combinations respectively; the IPC Mix includes an IPC template plasmid and an IPC primer-probe combination, wherein the IPC template plasmid is an artificially modified cloning plasmid with a sequence of SEQ ID NO.8, the IPC forward primer sequence is SEQ ID NO.9, the IPC reverse primer sequence is SEQ ID NO.10, and the IPC probe sequence is SEQ ID NO.
11.
6. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 5, characterized in that: The final concentrations of the IPC template plasmid and the IPC primer probe combination in the amplification system are: The final concentration of SEQ ID NO.8 was 2.48×10 5 copies / mL; the final concentration of SEQ ID NO.9 and SEQ ID NO.10 was 0.3 μM; the final concentration of SEQ ID NO.11 was 0.106 μM.
7. The kit for detecting the residual DNA content and fragment size distribution of E. coli cells according to claim 1, characterized in that: The kit includes 2×qPCR Mix, E. coli quantitative standard and DNA diluent; wherein 2×qPCR Mix includes 40mM Tris-HCl pH 7.8, 0.1U / μL Taq enzyme, 0.6mM dNTPs, 100nM ROX reference dye, 8mM Mg 2+ , 20% glycerol.
8. Use of the kit according to any one of claims 1 to 7 for quantitatively detecting the E. coli cell DNA content and fragment size distribution in intermediates, semi-finished products and finished products of biological products.
9. The use according to claim 8, characterized in that: The biological products are produced by using an E. coli cell expression system, and include antibody drugs, vaccines and recombinant proteins.
10. The use according to claim 8, characterized in that: The kit can accurately distinguish the sequences of E. coli cell DNA fragments with sizes of less than 100 bp, 100-199 bp, 200-499 bp, and 500-600 bp in biological products, and the quantitative limits of each detection system are 10 fg / μL.
Citation Information
Cited By
Kit and detection method for quantitatively detecting residual quantity of DNA (Deoxyribose Nucleic Acid) of host cell of pichia pastoris
CN121344255A
